Patrick D Spangler insider trades

Open-market stock purchases and sales by Patrick D Spangler, Director at OptimizeRx Corp, from SEC Form 4 filings since Nov 9, 2010.

Track record: 0% of 1 scored buy are up 5% or more since purchase, averaging -49%.

Recent trades

DateStockTradeValue
Jun 9, 2026OPRX OptimizeRx CorpBought (not open market)—

Companies traded

  • OPRX OptimizeRx Corp: 3 buys, 2 sales, last Jun 9, 2026
  • ULGX Urologix Inc: other filings, last Nov 6, 2014
  • EPOC Epocrates Inc: other filings, last Jan 20, 2012

Get free alerts when Patrick D Spangler files a new trade →